Lenvatinib
Inquiry
| Post Date: | Jun 05,2017 |
| Expiry Date: | Jun 05,2018 |
| Detailed Description: |
Cas No. :417716-92-8
Quantity: 50Kilograms Payment Method: treatment for differentiated thyroid carcinom Product name: Lenvatinib Synonyms: 4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide;E7080;E7080 (Lenvatinib);Lenvatinib (E7080);ER-203492-00;1-(4-(6-carbamoyl-7-methoxyquinolin-4-yloxy)-2-chlorophenyl)-3-cyclopropylurea;4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide XEN445;E70801-(4-(6-carbamoyl-7-methoxyquinolin-4-yloxy)-2-chlorophenyl)-3-cyclopropylurea CAS No.: 417716-92-8 Molecular formula: C21H19ClN4O4 Molecular weight: 426.85 Application: treatment for differentiated thyroid carcinoma |
| CAS Registry Number: | 417716-92-8 |
| Synonyms: | ;4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide;4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide; |
| Molecular Formula: | C21H19ClN4O4 |
| Molecular Weight: | 426.853 |
| Molecular Structure: | 
|
| Company: | Jinan Huicheng Pharm Tech Co., Ltd. [ China ] |
| Contact: | Lily |
| Tel: | 0531-68659623 |
| Fax: | |
| Email: | sales@hc-pharm.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
